Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

One-Step Method Screens Pregnant Women for Streptococci B

By LabMedica International staff writers
Posted on 27 May 2010
A new one-step method that screens pregnant women for the presence of group B streptococci (GBS) produces positive results as early as 6 hours after inoculation. More...


The Strep B carrot broth kit, a unique modification of Granada broth, is used for the selective enrichment and identification of beta-hemolytic group B streptococci (Streptococcus agalactiae) from clinical specimens.

The production of orange, red, or brick red pigment is a unique characteristic of hemolytic GBS due to reaction with substrates such as starch, proteose peptone, serum, and folate pathway inhibitors. These components serve as the basis for culture media used to detect and identify these organisms.

A product of Hardy Diagnostics (Santa Maria, CA, USA), modification of the Granada broth (the separation of the supplements) increases the shelf life of the product and ensures well-defined and reliable pigment production in the presence of GBS. The advantage of this medium is that it is a single tube system that does not require subculturing to a blood agar plate, unless the results are negative.

Carrot broth was found to be more sensitive than the Lim broth and Granada agar plate methods, and even polymerase chain reaction (PCR). It is also reliable for the preservation of GBS should the physician request susceptibility testing at a later date.

A companion product for Strep B carrot broth assists in the isolation and identification of the nonhemolytic strains of GBS (which comprise 0.5% - 5.9% of the total GBS isolates.) The GBS Detect plate is used when subculturing the negative Strep B carrot broth cultures. It contains selective agents and hemolysis enhancers to cause nonhemolytic strains to appear hemolytic, so they can easily be recognized and identified within 24 hours.

Approximately 10-35% of women are asymptomatic carriers of group B streptococci (GBS) in the genital and gastrointestinal tracts. GBS remains a leading cause of serious illness and death in newborn populations, and therefore, the detection of GBS in the vaginal-anorectal area is critical to the prevention of neonatal GBS disease.

Related Links:
Hardy Diagnostics



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.